| Literature DB >> 26980769 |
Serkan Ismail Göktuna1, Kateryna Shostak2, Tieu-Lan Chau2, Lukas C Heukamp3, Benoit Hennuy4, Hong-Quan Duong2, Aurélie Ladang2, Pierre Close5, Iva Klevernic2, Fabrice Olivier6, Alexandra Florin3, Grégory Ehx7, Frédéric Baron7, Maud Vandereyken8, Souad Rahmouni8, Lars Vereecke9, Geert van Loo9, Reinhard Büttner3, Florian R Greten10, Alain Chariot11.
Abstract
Constitutive Wnt signaling promotes intestinal cell proliferation, but signals from the tumor microenvironment are also required to support cancer development. The role that signaling proteins play to establish a tumor microenvironment has not been extensively studied. Therefore, we assessed the role of the proinflammatory Ikk-related kinase Ikkε in Wnt-driven tumor development. We found that Ikkε was activated in intestinal tumors forming upon loss of the tumor suppressor Apc Genetic ablation of Ikkε in β-catenin-driven models of intestinal cancer reduced tumor incidence and consequently extended survival. Mechanistically, we attributed the tumor-promoting effects of Ikkε to limited TNF-dependent apoptosis in transformed intestinal epithelial cells. In addition, Ikkε was also required for lipopolysaccharide (LPS) and IL17A-induced activation of Akt, Mek1/2, Erk1/2, and Msk1. Accordingly, genes encoding pro-inflammatory cytokines, chemokines, and anti-microbial peptides were downregulated in Ikkε-deficient tissues, subsequently affecting the recruitment of tumor-associated macrophages and IL17A synthesis. Further studies revealed that IL17A synergized with commensal bacteria to trigger Ikkε phosphorylation in transformed intestinal epithelial cells, establishing a positive feedback loop to support tumor development. Therefore, TNF, LPS, and IL17A-dependent signaling pathways converge on Ikkε to promote cell survival and to establish an inflammatory tumor microenvironment in the intestine upon constitutive Wnt activation. Cancer Res; 76(9); 2587-99. ©2016 AACR. ©2016 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26980769 DOI: 10.1158/0008-5472.CAN-15-1473
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701